Return On Equity of Oncotelic Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncotelic Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Oncotelic Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -22%, a 49% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2024 was -47%, a 19% increase from 2023.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2023 was -58%, a 312% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2022 was 28%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Oncotelic Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -22% +22% +49% 01 Jul 2025 30 Sep 2025
Q2 2025 -52% -41% -388% 01 Apr 2025 30 Jun 2025
Q1 2025 -51% +15% +23% 01 Jan 2025 31 Mar 2025
Q4 2024 -47% +11% +19% 01 Oct 2024 31 Dec 2024
Q3 2024 -44% +37% +46% 01 Jul 2024 30 Sep 2024
Q2 2024 -11% +62% +85% 01 Apr 2024 30 Jun 2024
Q1 2024 -66% -110% -252% 01 Jan 2024 31 Mar 2024
Q4 2023 -58% -86% -312% 01 Oct 2023 31 Dec 2023
Q3 2023 -81% -136% -248% 01 Jul 2023 30 Sep 2023
Q2 2023 -73% -139% -210% 01 Apr 2023 30 Jun 2023
Q1 2023 44% +185% 01 Jan 2023 31 Mar 2023
Q4 2022 28% +129% 01 Oct 2022 31 Dec 2022
Q3 2022 55% +161% 01 Jul 2022 30 Sep 2022
Q2 2022 66% +160% 01 Apr 2022 30 Jun 2022
Q1 2022 -141% -85% -154% 01 Jan 2022 31 Mar 2022
Q4 2021 -101% -37% -58% 01 Oct 2021 31 Dec 2021
Q3 2021 -107% -47% -78% 01 Jul 2021 30 Sep 2021
Q2 2021 -94% -29% -44% 01 Apr 2021 30 Jun 2021
Q1 2021 -56% +42% +43% 01 Jan 2021 31 Mar 2021
Q4 2020 -64% +25% +28% 01 Oct 2020 31 Dec 2020
Q3 2020 -60% +26% +30% 01 Jul 2020 30 Sep 2020
Q2 2020 -65% 01 Apr 2020 30 Jun 2020
Q1 2020 -97% 01 Jan 2020 31 Mar 2020
Q4 2019 -89% 01 Oct 2019 31 Dec 2019
Q3 2019 -86% 01 Jul 2019 30 Sep 2019

Oncotelic Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -47% +11% +19% 01 Jan 2024 31 Dec 2024
2023 -58% -86% -312% 01 Jan 2023 31 Dec 2023
2022 28% +129% 01 Jan 2022 31 Dec 2022
2021 -101% -37% -58% 01 Jan 2021 31 Dec 2021
2020 -64% +25% +28% 01 Jan 2020 31 Dec 2020
2019 -89% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.